NMN / NRStudienlage & Dosis

Top-Studien zu NMN / NR

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

1. 01

   Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.

   Ann Rheum Dis·2023·n=148Systematic Review138 einflussreiche Zitationen

   <h4>Objective</h4>To update the evidence on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with axial spondyloarthritis (axSpA) to inform the 2022 update of the Assessment of SpondyloArthritis…

2. 02

   Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

   Ann Rheum Dis·2023·n=107Systematic Review127 einflussreiche Zitationen

   <h4>Objective</h4>To update the evidence of non-biological treatments for axial spondyloarthritis (axSpA), as a basis for the 2022 Assessment of SpondyloArthritis international Society-European Alliance of Associations for Rheumatology…

3. 03

   Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.

   Arthritis Res Ther·2016·n=347Meta-Analysis98 einflussreiche Zitationen

   <h4>Background</h4>Peripheral disease (arthritis, enthesitis and dactylitis) and extra-articular disease (uveitis, psoriasis and inflammatory bowel disease) is common in ankylosing spondylitis (AS) and non-radiographic axial…

4. 04

   Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.

   Ann Rheum Dis·2015·n=309Meta-Analysis70 einflussreiche Zitationen

   <h4>Objectives</h4>This meta-analysis investigates the efficacy of tumour necrosis factor α (TNFα) blockers versus placebo for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis…

   Befund: After adjustment for publication year as a proxy for disease severity, the meta-analysis found no difference between ankylosing spondylitis and nr-axSpA trial effect sizes.

5. 05

   Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis.

   RMD Open·2019·n=60Meta-Analysis68 einflussreiche Zitationen

   Objectives To compare the clinical characteristics, burden of disease (eg, disease activity, function, quality of life), treatment modalities and treatment effect in patients with radiographic and non-radiographic axial Spondyloarthritis…

6. 06

   The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis.

   Arthritis Res Ther·2018·n=475Meta-Analysis62 einflussreiche Zitationen

   <h4>Background</h4>Depression is common among patients with axial spondyloarthritis (axSpA), but reports of its prevalence are highly variable. We performed a systematic review to (i) describe the prevalence of depression in axSpA, (ii)…

7. 07

   rTMS for suppressing neuropathic pain: a meta-analysis.

   J Pain·2009·n=149Meta-Analysis61 einflussreiche Zitationen

   <h4>Unlabelled</h4>This pooled individual data (PID)-based meta-analysis collectively assessed the analgesic effect of repetitive transcranial magnetic stimulation (rTMS) on various neuropathic pain states based on their neuroanatomical…

8. 08

   Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective.

   Nutrients·2025D52 einflussreiche Zitationen

   Heart failure represents the terminal stage in the development of many cardiovascular diseases, and its pathological mechanisms are closely related to disturbances in energy metabolism and mitochondrial dysfunction in cardiomyocytes. In…

9. 09

   Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).

   Cochrane Database Syst Rev·2015·n=435Meta-Analysis42 einflussreiche Zitationen

   <h4>Background</h4>Axial spondyloarthritis (axSpA) comprises ankylosing spondylitis (radiographic axSpA) and non-radiographic (nr-)axSpA and is associated with psoriasis, uveitis and inflammatory bowel disease. Non-steroidal…

10. 10

    NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

    Exp Gerontol·2020·n=154systematic41 einflussreiche Zitationen

    Nicotinamide adenine dinucleotide (NAD+) is an essential pyridine nucleotide that is present in all living cells. NAD+ acts as an important cofactor and substrate for a multitude of biological processes including energy production, DNA…

Häufige Fragen